James E. Talmadge

15.1k citations
251 papers · 11.7k indexed · 4 hit papers · h-index 52

Impact in

  • Immunology top 0.2%
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • T-cell and B-cell Immunology
  • Oncology top 0.5%
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immunotherapy and Immune Responses 66
    • Immune Cell Function and Interaction 63
    • Immune cells in cancer 29
    • T-cell and B-cell Immunology 24
    • Cancer Cells and Metastasis 22

James E. Talmadge

249 papers receiving 11.3k citations

Hit Papers

History of myeloid-derived suppressor cells 2013 · 960 citations
96019802026199520102505007501000

Peers

James E. Talmadge
Comparison fields: 5 of 154
  • Immunology 4.9k
  • Oncology 4.2k
  • Cancer Research 1.6k
  • Hematology 1.0k
  • Biotechnology 676
Replace Hiroshi Shiku with:
Hiroshi Shiku Japan
Ivan D. Horak United States
Peter J. Nelson Germany
Benjamin Bonavida United States
Reinhard Andreesen Germany
Jesús Prìeto Spain
William H. McBride United States
Francesco Colotta Italy
Elizabeth A. Grimm United States
Jonathan D. Powell United States
James E. Talmadge relative to Hiroshi Shiku Japan Hiroshi Shiku's profile →
Citations per field
00.5×1.5×1.8×
Hiroshi Shiku · 1×
Citations per year

Countries citing papers authored by James E. Talmadge

Since Specialization
Citations

This map shows the geographic impact of James E. Talmadge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Talmadge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Talmadge more than expected).

Fields of papers citing papers by James E. Talmadge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Talmadge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Talmadge. The network helps show where James E. Talmadge may publish in the future.

Co-authors

The 25 scholars most cited alongside James E. Talmadge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James E. Talmadge Line = papers co-authored together James E. Talmadge links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20239
2 201858
3 200921
4 200983
5 200829
6 20074
7 20056
8
Gene therapy of cancer - 12th International Conference.
20040
9 200021
10 20005
11 20008
12 199924
13 198896
14
Increase in liver-associated natural killer activity by polyribonucleotides.
198710
15
Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
198542
16
Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
198527
17
Optimization of an immunotherapeutic protocol with poly(I,C)-LC.
19854
18
Immunomodulation of natural killer activity by polyribonucleotides.
198522
19
Tumor growth and metastasis of B16-BL6 tumors following transfection of an allogeneic major histocompatibility complex (D(d) antigen
19852
20
Immunomodulation and antitumor effects of MVE-2 in mice.
198415

About James E. Talmadge

James E. Talmadge is a scholar working on Immunology, Oncology, Hematology, Biotechnology and Cancer Research, having authored 251 papers that have together received 11.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (66 papers), Immune Cell Function and Interaction (63 papers), Hematopoietic Stem Cell Transplantation (30 papers), Immune cells in cancer (29 papers), Cancer Research and Treatments (24 papers), T-cell and B-cell Immunology (24 papers), RNA Interference and Gene Delivery (22 papers) and Cancer Cells and Metastasis (22 papers). The work is most often cited by research in Immunology (4.9k citations), Oncology (4.2k citations), Cancer Research (1.6k citations), Hematology (1.0k citations) and Biotechnology (676 citations). James E. Talmadge has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Isaiah J. Fidler, Dmitry I. Gabrilovich, Lance A. Liotta, Unnur P. Thorgeirsson, Rakesh Kumar Singh, Patricia S. Steeg, Mark E. Sobel, Generoso Bevilacqua, L. Kópper and Jean R. Starkey. Their work appears in journals such as International Immunopharmacology, Cancer Immunology Immunotherapy, The Journal of Immunology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026